|
Market Closed -
NSE India S.E.
04:35:08 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,437.20 INR | -0.89% |
|
-3.09% | +19.75% |
| Market Cap | 69TCr 734.08Cr 631.6Cr 592.71Cr 542.28Cr 1.01TCr 1.02TCr 7.01TCr 2.73TCr 35TCr 2.76TCr 2.7TCr 1,14200Cr | P/E 2027 * |
29.9x | P/E 2028 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 66TCr 695.48Cr 598.39Cr 561.54Cr 513.76Cr 958.91Cr 966.51Cr 6.64TCr 2.59TCr 34TCr 2.61TCr 2.55TCr 1,08200Cr | EV / Sales 2027 * |
3.92x | EV / Sales 2028 * | 3.45x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.16% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| GLENMARK | Delayed | |
Bombay S.E.
| GLENMARK | Delayed |
Last Transcript : Glenmark Pharmaceuticals Limited
| 1 day | -0.89% | ||
| 1 week | -3.09% | ||
| Current month | -1.73% | ||
| 1 month | +9.54% | ||
| 3 months | +11.77% | ||
| 6 months | +19.49% | ||
| Current year | +19.75% |
| 1 week | 2,420 |  | 2,532.4 |
| 1 month | 2,202.2 | | 2,537.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | -3.09% | +22.42% | +220.05% | 734.08Cr | |
| -0.89% | -1.09% | +20.02% | +71.25% | 4.86TCr | |
| -1.72% | -1.15% | +47.28% | +115.51% | 4.13TCr | |
| -2.01% | -5.96% | +10.68% | +80.50% | 1.21TCr | |
| -0.70% | -2.70% | -12.22% | +11.80% | 1.19TCr | |
| +0.57% | -0.56% | +26.56% | +153.11% | 914.92Cr | |
| -1.01% | -5.16% | +21.57% | +41.99% | 748.61Cr | |
| -1.67% | -0.35% | +41.04% | -12.04% | 752.04Cr | |
| +0.03% | -2.72% | -42.28% | +14.39% | 519.04Cr | |
| -1.60% | -2.59% | +33.23% | +101.49% | 465.36Cr | |
| Average | -0.99% | -0.97% | +16.83% | +79.81% | 1.55TCr | |
| Weighted average by Cap. | -1.13% | -0.43% | +23.98% | +84.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 17TCr 177.64Cr 152.84Cr 143.43Cr 131.23Cr 244.93Cr 246.87Cr 1.7TCr 660.77Cr 8.58TCr 667.08Cr 652.53Cr 28TCr | 19TCr 197.95Cr 170.32Cr 159.83Cr 146.23Cr 272.93Cr 275.09Cr 1.89TCr 736.31Cr 9.56TCr 743.34Cr 727.13Cr 31TCr |
| Net income | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 233.51Cr 91Cr 1.18TCr 92Cr 90Cr 3.8TCr | 2.77TCr 29Cr 25Cr 24Cr 22Cr 40Cr 41Cr 279.95Cr 109.02Cr 1.42TCr 110.06Cr 107.66Cr 4.56TCr |
| Net Debt | -3.65TCr -39Cr -33Cr -31Cr -29Cr -53Cr -54Cr -368.7Cr -143.59Cr -1.86TCr -144.96Cr -141.8Cr -6.01TCr | -4.8TCr -51Cr -44Cr -41Cr -38Cr -70Cr -71Cr -485.02Cr -188.89Cr -2.45TCr -190.69Cr -186.53Cr -7.9TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | ₹2,437.20 | -0.89% | 4,12,728 |
| 03/26/03 | ₹2,459.00 | -0.04% | 4,81,343 |
| 02/26/02 | ₹2,460.00 | -0.42% | 5,16,029 |
| 01/26/01 | ₹2,470.40 | -0.39% | 6,79,565 |
| 31/26/31 | ₹2,480.00 | -1.39% | 9,11,026 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
